CytoSorb Therapy in COVID-19 (CTC) Patients Requiring Extracorporeal Membrane Oxygenation: A Multicenter, Retrospective Registry

CytoSorb Therapy in COVID-19 (CTC) Patients Requiring Extracorporeal Membrane Oxygenation: A Multicenter, Retrospective Registry

Introduction: CytoSorb extracorporeal blood purification therapy received FDA Emergency Use Authorization (EUA) to suppress hyperinflammation in critically ill COVID-19 patients. The multicenter CTC Registry was established to systematically collect patient-level data, outcomes, and utilization patt...

Full description

Bibliographic Details
Main Authors: Tae Song, Jeremiah Hayanga, Lucian Durham, Lawrence Garrison, Paul McCarthy, Andy Barksdale, Deane Smith, Robert Bartlett, Mark Jaros, Peter Nelson, Zsolt Molnar, Efthymios Deliargyris, Nader Moazami
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-12-01
Series:Frontiers in Medicine
Subjects:
coronavirus–COVID-19
ECMO–extracorporeal membrane oxygenation
ICU–intensive care unit
mortality
inflammation
hemoperfusion
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2021.773461/full

Internet

https://www.frontiersin.org/articles/10.3389/fmed.2021.773461/full

Similar Items